Quantitative Detection of Parkinson's Disease Symptoms Advisor: Dr. Chris Kao Project Team: Kylen Bares Eddie Cao.

Slides:



Advertisements
Similar presentations
Parkinson’s Disease (PD)
Advertisements

The PARticulars of Parkinson’s Disease
An Overview of Conventional and Experimental Treatments
Stead-Ease BME Senior Design Midterm Presentation October 22, 2009 Andrea Castaneda - Daniel Miranda - Jennifer Wang - Kevin Yeroushalmi - Joseph Youssef.
Kelsie Chasan Gianni Grasso.  7-10 million diagnosed  60,000 diagnosed each year  Majority over 50 years old  Men more likely.
Movement part 2. Cerebellum and Brainstem KW p. 363.
Brain Control of Movement. Motor Control Hierarchy  High level – plans and executes strategy Association areas of cortex Basal ganglia gives the “go”
DBS on Parkinson’s Disease By: Christopher Ross DeSanto BME 181 / February 11, 2010.
Medical Robotics Application for Motion Emulation of Parkinsonian ECE 7995 Advisor Dr. Abhilash Pandya Group #2 Ranvir Hara Ravanpreet Kaur Gaganjeet Hans.
Parkinson’s disease Interventions Whitney Mundy Dr. Davis.
Parkinson’s Test Device Development Erin Sikkel and Tiffany Feltman.
Parkinson’s Test Device Development Erin Sikkel and Tiffany Feltman.
Nerve Cell Regeneration Heather Wilson and Alicia DiCola.
Module 7.3 Movement Disorders. Parkinson’s Disease A neurological disorder characterized by muscle tremors, rigidity, slow movements and difficulty initiating.
Is it a neurodegenerative brain disorder that progresses slowly in most people.
What is Aging? Alzheimer’s Disease Parkinson’s Disease.
Recreational Therapy: An Introduction Chapter 11: Physical Medicine and Rehabilitation Practice PowerPoint Slides.
Nervous System Human Body Systems Project Caroline Crinion.
Parkinson’s Disease By Devin Cornford
Parkinson’s Disease. Definition Parkinson's disease (PD) is an idiopathic, slowly progressive, neurodegenerative disorder whereby two or more of the following.
MODELING THE PARKINSONIAN TREMOR AND ITS TREATMENT Supervisor : Dr Towhidkhah Designed by Yashar Sarbaz Amirkabir University of Technology.
Surgery for Parkinson’s Disease: Focus on Deep Brain Stimulation Ramón L Rodríguez, MD Director of Clinical Services University of Florida Movement Disorders.
BY: MACKENZIE SOARES ALYSSA MEDIEROS STEPHANIE GARDNER Parkinson's Disease.
PARKINSON’S DISEASE By Courtney and Niral. WHAT IS IT?  Parkinson's disease (PD) is chronic and progressive movement disorder, meaning that symptoms.
PhD MD MBBS Faculty of Medicine Al Maarefa Colleges of Science & Technology Faculty of Medicine Al Maarefa Colleges of Science & Technology Lecture – 9:
Adult Medical-Surgical Nursing Neurology Module: Parkinson’s Disease.
Mostly Parkinson’s disease but also few other movement disorders due to diseases of the basal ganglia.
Printed by Parkinson’s Disease Rigidity Quantification Kylen Bares, Eddie Cao Vanderbilt University, Department of Biomedical Engineering,
 Parkinson Disease (PD) is a disorder of the brain that causes a variety of movement problems.
 Parkinson’s Disease (PD) -progressive neurodegenerative disease affecting motor ability -third most common neurologic disorder of older adults.
NERVOUS SYSTEM Sydney Hirrschoff. NERVOUS SYSTEM FUNCTION The nervous system is made up of the brain, spinal cord, sensory organs, and all of the nerves.
Quantitative Detection of Parkinson's Disease Symptoms Advisor: Dr. Anita Mahadevan-Jansen Faraz Ali James Lugge Ernest Moore Mahesh Parlikad.
Quantitative Detection of Parkinson's Disease Symptoms Advisor: Dr. Chris Kao Project Team: Kylen Bares Eddie Cao.
Parkinson’s Test Device Development Tiffany Feltman 1 and Erin Sikkel 1 Advisors: Dr. Paul King 1, Dr. Peter Konrad 2, Judith Dexheimer 3, Randy Carnevale.
SYMPTOMS: Tremors, stiff muscles Shuffling gait, Poor coordination Balance problems, Fatigue Speech & swallowing difficulties TREATMENTS: Medications.
By: Alejandro Navarro and Andrea Ors. Content Introduction What is Parkinson's disease? What causes the disease? History Main symptoms Treatment Statistics.
Quantitative Detection of Parkinson's Disease Symptoms Advisor: Dr. Anita Mahadevan-Jansen Faraz Ali James Lugge Ernest Moore Mahesh Parlikad.
second most common neurodegenerative disorder progressive loss of muscle control trembling of the limbs and head while at rest stiffness, slowness, and.
By: Madison Knode, Emma Starkey, Carley Robinson.
By Katelyn Chaimson and Sean Guyot
Parkinson's disease By Colby Allen. symptoms Mild to major tremors. Rigidity or joint stiffness Bradykinesia or slowness of movement Postural instability.
Parkinson’s Test Device Development Tiffany Feltman Erin Sikkel.
Pathogenesis and pathology of parkinsonism
By Seamus Hogan.  Parkinsons disease is degenerative disorder of the central nervous system. it causes the dopamine to contain cells in the substantial.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Deep Brain Stimulation Surgery in India. Deep Brain Stimulation can help to treat with many symptoms caused by the following movement disorders: Parkinson’s.
Do Now 2/9/15 1.Describe possible causes for forgetting a memory. 2.Compare and contrast semantic and episodic memories.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Pharmacological Treatment of Parkinson Disease: A.
How is Parkinson’s disease Diagnosed? And What Are the Treatment options?
Parkinson's disease ♦ Is a neurodegenerative disorder ♦ Develops around age 50 * incidence rises with age * affects 1-2% of population > age 65 ♦ Higher.
Quantitative Detection of Parkinson's Disease Symptoms Advisor: Dr. Anita Mahadevan-Jansen Faraz Ali James Lugge Ernest Moore Mahesh Parlikad.
“HEALTH IS THE BEST” In the name of God. WHAT IS IT? Parkinson's disease (PD) is a chronic and progressive movement disorder, meaning that symptoms.
Parkinson’s Disease Jose S. Santiago M.D..
Parkinson’s Disease Celsey and Chylee.
Falon Fiorillo & Breeanna Fournier
Parkinson's disease KRZYSZTOF NICPOŃ.
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
The Nervous System.
Parkinson’s disease.
Parkinson's disease Parkinson's disease (PD) is the second-most common
Long Term Effects of Concussions
NERVOUS SYSTEM PROBLEMS
BIO-NANOTECHNOLOGY Size: 1mm x 1mm x 5mm
ANTIPARKINSONS Drugs By Dr. Mirza Shahed Baig.
Quantitative Detection of Parkinson's Disease Symptoms
Ch. 7: Neurons: Matter of the Mind Ch. 8: The Nervous System
Quantitative Detection of Parkinson's Disease Symptoms
Lucas McDuff and Meghan Mumpower
Lucas McDuff and Meghan Mumpower
HOW DOES EXPERIENCE AFFECT BEHAVIOUR AND MENTAL PROCESSES?
Presentation transcript:

Quantitative Detection of Parkinson's Disease Symptoms Advisor: Dr. Chris Kao Project Team: Kylen Bares Eddie Cao

Dr. Changquing (Chris) Kao, M.D., Ph.D. Research Associate Professor in Department of Neurosurgery at Vanderbilt University Clinical interest: –Microelectrode brain mapping for target localization of deep brain stimulation treatment of movement disorders Research focus: –Electrophysiology in nerve stimulation, epilepsy, pain control and head injury

What is Parkinson’s Disease? Neurodegenerative disorder caused by damaged or dead dopamine-neurons in the substantia nigra Dopamine: neurotransmitter that carries information from neuron to neuron and eventually out to the muscles Brain no longer able to direct or control muscle movement in a normal manner. Half a million people every year are affected by Parkinson’s

Symptoms Tremor or trembling in hands, arms, legs, jaw, and face Rigidity or stiffness of the limbs and trunk Slowness of motor movements Postural instability or impaired balance and coordination Reduced blink rate of eyes

Treatment Drugs: Levodopa/ L-Dopa Drugs designed to mimic dopamine effects or counteract acetylcholine effects Pallidotomy: Section of globus pallidus removed Deep Brain Stimulation (DBS) : Implants stimulators that block brain signals causing rigidity, tremors and other symptoms

Problem Quantifiable measurement of the symptoms of Parkinson’s disease is needed to maximize therapy. Unfortunately, there currently does not exist a method known to be reliable.

Our Proposed Device Diagnostic tool that uses pneumatic cylinders to cause movement of the arm before and during DBS surgery. Displays the pressure needed to move the arm. This pressure is multiplied by the cross-sectional area of the cylindrical piston to calculate the force. Force needed to move the arm is directly proportional to the rigidity of the muscle.

Our Device A pneumatic-actuated frame that fits around the right arm - uses air pressure for individual flexion of the fingers, hand, and forearm - measures the pressure exerted on the actuator piston - this pressure corresponds to the force needed to move the arm and, therefore, the rigidity of the arm muscles Each patient will be their own control since we only need to measure effectiveness of treatment

Our Device Composed of two main parts –Control Box Contains the pneumatic valves and pressure manifold –Arm frame Encloses the arm and translates motion of pneumatic cylinder into motion of arm

Current Status Acquired materials for control box and pneumatic actuators for arm frame Control box is complete, pending a minor change in tube layout. Acquired access to a life-size dummy to design our frame around

Ultimate Goals To create and test the viability of a fully controllable pneumatic device that forces movement in the arms of actual Parkinson’s patients and accurately displays the required pressure to induce movement. To enable the device to adjust in order to comfortably fit multiple patients.